Zoe scores companies across nine operational dimensions — finance, delivery, culture, leadership, market, GTM, vision, product, risk — weighted by company stage and rolled into a single composite score. No surveys. No interviews. Results in 24 hours.
Weights sum to 100% at every stage. The same nine dimensions are measured for every company — what changes is how much each contributes to the composite Zoe Score.
Every Zoe diagnostic produces a composite score from 0 to 100, derived from nine weighted dimension sub-scores. Here's what one looks like for a real Series A SaaS company.
One number, computed from nine weighted dimensions. This sample is a Series A SaaS company — strong on market and product, weak on culture and finance.
Financial Vitality and Delivery & Execution are the foundation of operational health. Together they account for nearly half the composite score because if the engine isn't funded and isn't shipping, nothing else matters.
Culture, leadership, market position, and go-to-market form the operational middle layer. Traditional DD touches these unevenly — Zoe measures all four with the same rigor.
Do people want to stay?
Measures the health of the human system — employee satisfaction, retention signals, psychological safety, leadership trust, and whether the company is investing in its people. Culture problems are leading indicators of execution problems.
Healthy
eNPS above 30.
At Risk
eNPS below 10.
Is leadership sustainable?
Assesses the health and effectiveness of the executive team — burnout risk, decision-making speed, delegation patterns, and whether leaders have space for strategic thinking versus constant firefighting.
Healthy
Burnout risk below 4.
At Risk
Burnout risk above 6.
Is the market pulling or pushing?
Evaluates the company's position within its market — TAM penetration trajectory, competitive win rates, differentiation strength, and whether demand is growing or the company is swimming against the current.
Healthy
TAM growing above 5% YoY.
At Risk
TAM flat or contracting.
Is the pipeline real?
Measures the go-to-market engine — pipeline health, unit economics, brand visibility, sales efficiency, and channel diversification. A strong product with a weak GTM engine still fails.
Healthy
Pipeline coverage above 3x.
At Risk
Pipeline coverage below 2x.
Vision, product-customer fit, and risk exposure round out the model. Smaller weights, but each one catches problems the other six can't see.
Does the roadmap hold up?
Evaluates strategic clarity and execution against the company's stated vision — milestone completion, team alignment on direction, and whether the company has contingency plans if the primary strategy fails.
Are customers thriving?
Monitors product delivery health and customer satisfaction — shipping velocity, customer happiness signals, onboarding efficiency, churn trends, and the innovation pipeline that determines future value.
What could break this?
Identifies existential and structural risks — AI disruption exposure, key person dependencies, customer concentration, and black swan preparedness.
Most diligence stops at finance and legal. The six categories below are the operational blind spots that show up in post-close performance — and the reason Zoe measures all nine.
Survey-based culture checks miss the leading indicators. By the time NPS drops, your top engineers are already interviewing.
Velocity charts in board decks are vanity metrics. Real signal lives in deploy frequency, on-time delivery, and unplanned firefighting.
Founder fatigue is the single biggest leading indicator of underperformance. No traditional DD process measures it.
Burn multiple is a 2-week diligence question, but it changes monthly. Without continuous tracking, you find out at the next board meeting.
Vision decks are easy. Connecting strategy to actual roadmap traction requires the eng + product + finance signal in one place.
Compliance questionnaires are point-in-time. Real risk exposure shifts with every new vendor, hire, and integration.
If you're evaluating Zoe for your firm or portfolio, these are the questions that come up in every first call.
Zoe pulls data directly from the systems your company already runs — accounting, CRM, HRIS, eng tools, infrastructure monitoring. Metadata only, no PII. We never ask your team to fill out a form.
Weights are stage-aware. A pre-seed company is judged differently than a PE portfolio company — Financial Vitality dominates at growth stage but C-Suite is heavier at pre-seed. The full weighting table is shown above in the interactive visual.
Each metric has a confidence score. Missing data lowers confidence on that dimension but does not zero it out — Zoe falls back on adjacent signals (e.g., delivery velocity proxies for execution if sprint data is missing).
Yes. Every score is traceable down to the underlying metrics, sources, and timestamps. Zoe is auditable end-to-end — no black box.
After the initial 24-hour diagnostic, scores refresh weekly as new data flows from connected systems. PE portfolio customers can configure daily refresh on flagged companies.
75+ is Healthy. 55–74 is Watch. Below 55 is At Risk. The bands are derived from the historical distribution of all scored companies, not arbitrary thresholds.
Get a composite score across all nine dimensions, plus a 100-day action plan, in 24 hours.
Join 200+ firms on the waitlist
